News
- Author:
- Mark S. Lesney, PhD
Publish date: April 7, 2021
Real-world evidence from the largest series of TTP patients receiving caplacizumab provides confirmation of the t...
News
- Author:
- Mark S. Lesney, PhD
Publish date: March 25, 2021
Graft failure is a potentially severe complication in patients treated with allogeneic hematopoietic stem cell tr...
News
- Author:
- Mark S. Lesney, PhD
Publish date: March 24, 2021
Transplantation at 4 months after Mab treatment was initiated showed significant benefits in overall and disease-...
News
- Author:
- Mark S. Lesney, PhD
Publish date: March 18, 2021
The main threat to the vast majority of children with acute lymphoblastic leukemia still remains the ALL itself. ...
News
- Author:
- Mark S. Lesney, PhD
Publish date: March 17, 2021
Conventional chemotherapy plus rituximab (R-CHOEP-14) was compared to high-dose chemotherapy plus rituximab follo...
News
- Author:
- Mark S. Lesney, PhD
Publish date: March 12, 2021
Pirtobrutinib (formerly known as LOXO-305) is an oral-dose, highly selective, reversible inhibitor.
News
- Author:
- Mark S. Lesney, PhD
Publish date: February 17, 2021
The researchers calculated risk scores using their prognostic gene set in three additional published DLBCL studies.
News
- Author:
- Mark S. Lesney, PhD
Publish date: February 9, 2021
Patients with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis were assessed for their immune response.
News
- Author:
- Mark S. Lesney, PhD
Publish date: February 3, 2021
Immunoabsorption therapy targeting factor VIII inhibitors appeared effective, but the researchers suggest that mo...
News
- Author:
- Mark S. Lesney, PhD
Publish date: January 29, 2021
The primary outcome of the study was to assess the efficacy and toxicity of C/T therapy.
News
- Author:
- Mark S. Lesney, PhD
Publish date: January 27, 2021
STI incidence was determined using 2018 data and was highest in the 15- to 24 year-old age bracket.
News
- Author:
- Mark S. Lesney, PhD
Publish date: January 25, 2021
Approval of Cabenuva was based upon two randomized, open-label, controlled clinical trials in 1,182 HIV-infected ...
News
- Author:
- Mark S. Lesney, PhD
Publish date: January 21, 2021
The stockpile, which is maintained in Switzerland, is designed to be readily deployed to other countries whenever...
News
- Author:
- Mark S. Lesney, PhD
Publish date: January 20, 2021
Allogeneic hematopoietic stem-cell transplantation improved disease-free survival, compared with Berlin-Frankfurt...
News
- Author:
- Mark S. Lesney, PhD
Publish date: January 15, 2021
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C r...
